MARIE MCDERMOTT: Open Payments
NPI 1407151418 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 20 payments from 9 companies in 2025. Trend: 2023 $848 · 2024 $383 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $82 |
| Aimmune Therapeutics, Inc. | 4 | $61 |
| PFIZER INC. | 3 | $57 |
| Amgen Inc. | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $13 |
Products named: VRAYLAR, ZENPEP, PREVNAR 20, EVENITY, REXULTI, ROTATEQ, REPATHA, XIFAXAN.
Industry payments across AZ — which companies pay providers there.
